Bitcoin price today: gains to $120k, near record high on U.S. regulatory cheer
Waystar Holding Corp (NASDAQ:WAY), a $6.5 billion healthcare technology company currently trading at $37.41, saw its Chief Technology Officer Christopher L. Schremser sell 8,623 shares of common stock on July 10, 2025, for approximately $324,461. The sales occurred at weighted average prices ranging from $37.2100 to $37.9900. According to InvestingPro analysis, the stock appears to be trading above its Fair Value.
On the same day, Schremser also exercised options to acquire 8,623 shares of Waystar Holding Corp. common stock at an exercise price of $4.14, for a total value of $35,699. The transaction comes as the company maintains strong financial health with a current ratio of 3.12, and its stock has delivered an impressive 75% return over the past year.
Following these transactions, Schremser directly owns 438,044 shares of Waystar Holding Corp. The sale was executed automatically according to a pre-arranged 10b5-1 trading plan adopted on December 6, 2024. For deeper insights into Waystar’s valuation and financial metrics, including 11 additional ProTips, check out the comprehensive Pro Research Report available on InvestingPro.
In other recent news, Waystar Holding Corp. reported a 19% revenue growth last year, surpassing its long-term target, largely due to new customer contracts following a competitor’s cyberattack. Mizuho (NYSE:MFG) initiated coverage on Waystar with an outperform rating and a $48 price target, citing revenue and earnings per share estimates above consensus for 2025-2027. Fitch Ratings upgraded Waystar’s Long-Term Issuer Default Rating to ’BB’ from ’BB-’, highlighting reduced leverage and strong recurring revenue streams. S&P Global Ratings also upgraded Waystar’s credit rating to ’BB-’ from ’B+’, reflecting a stronger market position and decreasing leverage. Additionally, Waystar announced the appointment of Aashima Gupta from Google (NASDAQ:GOOGL) Cloud and Michael Roman, former CEO of 3M, to its Board of Directors, bringing significant expertise in healthcare and technology. The company disclosed a proposed public offering of 12.5 million shares by major shareholders, with no shares being sold by Waystar itself. This offering is managed by J.P. Morgan, Goldman Sachs & Co. LLC, and Barclays (LON:BARC). The company’s financial sponsors, EQT (ST:EQTAB), Bain Capital, and CPPIB, reduced their ownership, potentially signaling a shift in control over the coming years.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.